You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雲頂新耀-B(1952.HK)暗盤大幅收漲30% 每手賺8250港元
格隆匯 10-08 18:35
格隆匯10月8日丨雲頂新耀-B(1952.HK)暗盤交投活躍,大幅成交2.78億港元,收報71.5港元,較招股價55港元上漲30%,每手浮盈8250港元,最新總市值202.8億港元。雲頂新耀是一家生物製藥公司,自2017年創立以來已打造一個由八款極具前景的臨牀階段候選藥物組成的產品組合。公司的控股股東為亞洲最大醫療保健專門投資企業C-BridgeCapital(CBC),持股62.40%、淡馬錫全資子公司Palace Investments持股1.42%、高瓴資本持股3.15%。公開發售階段雲頂新耀獲654.41倍認購,分配至公開發售的發售股份最終數目為3177.4萬股,佔發售股份總數的約50%(於任何超額配股權獲行使前)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account